MedPath

Donor After Circulatory Death Heart CAP Trial

Not Applicable
Completed
Conditions
Heart Transplant
Interventions
Device: Transplant
Registration Number
NCT04615182
Lead Sponsor
TransMedics
Brief Summary

The Portable Organ Care System (OCS™) Heart for Resuscitating, Preserving and Assessing Hearts Donated after Circulatory Death Continued Access Protocol (OCS DCD Heart CAP)

Detailed Description

To enable continued clinical access to DCD heart transplantation in the U.S. and to continue to collect additional data on the performance of the OCS Heart System to resuscitate, preserve and assess hearts donated after circulatory death for transplantation to increase the pool of donor hearts available for transplantation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • • Primary heart transplant candidates

    • Age ≥ 18 years old
    • Signed: (1) written informed consent document; (2) authorization to use and disclose protected health information; and (3) consent to TransMedics' use of recipients' UNOS/OPTN data and recipients' INTERMACS data.

Recipient

Exclusion Criteria
  • Prior solid organ or bone marrow transplant

    • Chronic use of hemodialysis or diagnosis of chronic renal insufficiency
    • Multi-organ transplant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
OCS PreservationTransplant-
Primary Outcome Measures
NameTimeMethod
Patient Survival6 months post-transplant

Patient survival at 6 months post-transplant.

Secondary Outcome Measures
NameTimeMethod
Utilization Rate24 hours post transplant

Utilization Rate, defined as the number of eligible DCD donor hearts that met the warm ischemic time limit per protocol and were instrumented on the OCS Heart System that meet the acceptance criteria for transplantation after OCS Heart preservation divided by the total number of eligible DCD donor hearts that met the warm ischemic time limit above and were instrumented on the OCS Heart System.

Trial Locations

Locations (25)

Northwestern University

🇺🇸

Evanston, Illinois, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

University of California San Diago

🇺🇸

La Jolla, California, United States

Cedars Sinai

🇺🇸

Los Angeles, California, United States

Stanford University

🇺🇸

Palo Alto, California, United States

Mayo Clinic Florida

🇺🇸

Jacksonville, Florida, United States

Emory University Hospital

🇺🇸

Atlanta, Georgia, United States

Tufts Medical Center

🇺🇸

Boston, Massachusetts, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

Nyph/Cumc

🇺🇸

New York, New York, United States

Westchester Medical Center

🇺🇸

Valhalla, New York, United States

Sentara

🇺🇸

Norfolk, Virginia, United States

St. Vincent Cardiovascular Research Institute

🇺🇸

Indianapolis, Indiana, United States

Minneapolis Heart Institute

🇺🇸

Minneapolis, Minnesota, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Duke University

🇺🇸

Durham, North Carolina, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Froedtert & the Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Yale New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

AdventHealth Orlando

🇺🇸

Orlando, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

Virginia Commonwealth University

🇺🇸

Richmond, Virginia, United States

Montefiore

🇺🇸

Bronx, New York, United States

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath